The incidence and characteristics of silent cerebral infarction in elderly diabetic patients: Association with serum-soluble adhesion molecules

Diabetologia

Volumn 41, Issue 8, 1998, Pages 911-917

  Kawamura, T ^a   Umemura, T ^a   Kanai, A ^a   Uno, T ^a   Matsumae, H ^a   Sano, T ^a   Sakamoto, N ^a   Sakakibara, T ^a   Nakamura, J ^b   Hotta, N ^b  

^a CHUBU ROSAI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adhesion molecules; Carotid artery; Diabetes mellitus; E selectin; ICAM 1; Silent cerebral infarction; VCAM 1

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; BRAIN INFARCTION; CELL ADHESION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; FIBRINOLYSIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CAROTID ARTERIES; CELL ADHESION MOLECULES; CEREBRAL INFARCTION; DIABETES MELLITUS, TYPE 2; E-SELECTIN; FEMALE; FIBRINOLYSIS; HUMANS; HYPERTENSION; INTERCELLULAR ADHESION MOLECULE-1; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 15444343871     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051007     Document Type: Conference Paper

References (49)

1. Ross R (1986) The pathogenesis of atherosclerosis-an update. N Engl J Med 314: 488-500
2. Editorials (1992) Atherosclerosis goes to the wall. Lancet 339: 647-648
3. Collins T (1993) Biology of disease. Endothelial nuclear factor-kB and the initiation of the atherosclerotic lesion. Lab Invest 68: 499-508
4. Carter AM, Grant PJ (1997) Vascular homeostasis, adhesion molecules, and macrovascular disease in non-insulin-dependent diabetes mellitus. Diabet Med 14: 423-432
5. Cybulsky MI, Gimbron Jr MA (1991) Endothelial expression of mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791
6. Poston RN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR (1992) Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 140: 665-673
7. Endres M, Laufs U, Merz H, Kaps M (1997) Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke 28: 77-82
8. Gearing A J H, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14: 506-512
9. Gearing A J, Hemingway I, Pigott R, Hughes J, Rees AJ, Cashman SJ (1992) Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Annals NY Acad Sci 667: 324-331
10. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD (1994) Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thromb Haemostasis 72: 979-984
11. Roep BO, Heidenthal E, de Vries RRP, Kolb H, Martin S (1994) Soluble forms of intercellular adhesion molecule-1 in insulin-dependent diabetes mellitus. Lancet 343: 1590-1593
12. Cominacini L, Pasini AF, Garbin U et al. (1995) Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: relation to metabolic control. Diabetologia 38: 1122-1124
13. Fasching P, Waldhäusl W, Wagner OF (1996) Elevated circulating adhesion molecules in NIDDM - potential mediators in diabetic macroangiopathy. Diabetologia 39: 1242-1244 (Letter)
14. Fasching P, Veitl M, Rohac M, Streli, Schneider B, Waldhäusl W, Wagner OF (1996) Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81: 4313-4317
15. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayaina S (1997) Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46: 2096-2101
16. Awad IA, Spetzler RF, Hodak JA, Awad CA, Carey R (1986) Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors. Stroke 17: 1084-1089
17. Lechner H, Schmidt R, Bertha G, Justish E, Offenbacher H, Schneider (1988) Nuclear magnetic resonance image while matter lesions and risk factors for stroke in normal individuals. Stroke 19: 263-265
18. Kase CG, Wolf PA, Chodosh EH et al. (1989) Prevalence of silent stroke in patients presenting with initial stroke: The Framingham study. Stroke 20: 850-852
19. Jørgensen HS, Nakayama H, Raaschou HO, Gram J, Olsen TS (1994) Silent infarction in acute stroke patients. Prevalence, localization, risk factors and clinical significance: The Copenhagen stroke study. Stroke 25: 97-104
20. Shinkawa A, Ueda K, Kiyohara Y et al. (1995) Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama study. Stroke 26: 380-385
21. Tuszynski MH, Petito CK, Levy D (1989) Risk factors and clinical manifestations of pathologically verified lacunar infarctions. Stroke 20: 990-999
22. Handa N, Matsumoto M, Maeda H et al. (1990) Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21: 1567-1572
23. Kawamori R, Yamasaki Y, Matsushima H et al. (1992) Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15: 1290-1294
24. Hougaku H, Matsumoto M, Handa N et al. (1994) Asymptomatic carotid lesions and silent cerebral infarction. Stroke 25: 566-570
25. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli P (1994) Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17: 1330-1336
26. Yamasaki Y, Kawamori R, Matsushima H et al. (1995) Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 38: 585-591
27. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R (1986) Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74: 1399-1406
28. Ohmura T, Ueda K, Kiyohara Y et al. (1993) Prevalence of type 2 (non-insulin-dependent) diabetes mellitus and impaired glucose tolerance in the Japanese general population: the Hisayama study. Diabetologia 36: 1198-1203
29. Kobayashi S, Okada K, Yamashita K (1991) Incidence of silent lacunar lesion in normal adults and its relation to cerebral blood flow and risk factors. Stroke 22: 1379-1383
30. Hougaku H, Matsumoto M, Kitagawa K et al. (1992) Silent cerebral infarction as a form of hypertensive target organ damage in the brain. Hypertension 20: 816-820
31. Matsubayashi K, Shimada K, Kawamoto A, Ozawa T (1992) Incidental brain lesions on magnetic resonance imaging and neurobehavioral functions in the apparently healthy elderly. Stroke 23: 175-180
32. Fujikawa T, Yamawaki S, Touhouda Y (1993) Incidence of silent cerebral infarction in patients with major depression. Stroke 24: 1631-1634
33. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E (1996) Diabetes mellitus as a risk factor for death from stroke. Stroke 27: 210-215
34. Kawai N, Keep RF, Betz AL (1997) Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 28: 149-154
35. Kuusisto J, Mykkanen L, Pyorala K, Laakso M (1994) Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25: 1157-1164
36. Sobel RA, Mitchell ME, Fondren G (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol 136: 1309-1316
37. Hess DC, Zhao W, Carroll J, McEachin M, Buchanan K (1994) Increased expression of ICAM-1 during reoxygenation in brain endothlial cells. Stroke 25: 1463-1468
38. Okada Y, Copeland BR, Mori E, Tung M-M, Thomas WS, del Zoppo GJ (1994) P-selectin and intracellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25: 202-211
39. Matsuo Y, Yamasaki Y, Kogure K (1996) Inflammatory reaction after brain damage and prospective therapy against damage impending cerebral infarction. Keio J Med 45: 270-274
40. Lindsherg PJ, Carpén O, Paetau A, Karjalainen-Lindsberg M-L, Kaste M (1996) Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke. Circulation 94: 939-945
41. Shyu K-G, Chang H, Lin C-C (1997) Serum levels of intercellular adhesion molecule-1 and E-selectin in patients with acute ischaemic stroke. J Neurol 244: 90-93
42. Liu T, Clark RK, McDonnell PC et al. (1994) Tumor necrosis factor-α expression in ischemic neurons. Stroke 25: 1481-1488
43. Clark WM, Madden KP, Rothlein R, Zivin JA (1991) Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment. Stroke 22: 877-883
44. del Zoppo GJ, Schmid-Schönbein GW, Mori E, Copeland BR, Chang C-M (1991) Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 22: 1276-1283
45. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E (1996) Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol 92: 747-750
46. Schmidt AM, Hori O, Chen JX et al. (1995) Advanced glycation endproducts interacting with their endothelial receptor induced expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96: 1395-1403
47. Yokote K, Morisaki N, Zenibayashi M et al. (1993) The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cell via the expression of adhesion molecules. Eur J Biochem 217: 723-729
48. Ishizuka T, Suzuki K, Kawakami M et al. (1994) DP-1904, a specific inhibitor of thromboxane A2 synthesizing enzyme, suppresses ICAM-1 expression by stimulated vascular endothelial cells. Eur J Pharmacol 262: 113-123
49. Blann, AD, Tse W, Maxwell S Jr, Waite MA (1994) Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertension 12: 925-928